Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
“Olainfarm” plans to increase dividends, strengthens its product portfolio in export markets
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids Citi
Valoda EN
Statuss Publicēts
Versija
Datums 2012-05-13 21:19:35
Versijas komentārs
Teksts

Olaine, May 13, 2012

 “Olainfarm” plans to increase dividends, strengthens its product portfolio in export markets


AS “Olainfarm” is currently finishing registration of capsules of “Noofen” in Russia, plans to start selling capsules of
“Olvazol” in Ukraine in September and has started the registration of “Neiromidin” in China, Chairman of the Board Mr
Valerijs Maligins told in his interview to portal naudaslietas.lv. AS “Olainfarm” plans to gradually increase share of profit
payable in dividends, so that in more distant future it might be as high as 90% of profit.

“More significant growth in the future could be achieved if we through share issues purchase new companies,” says Valerijs
Maligins, Chairman of the Board of AS “Olainfarm”. “In order to keep all financial options open, “Olainfarm” has to be
attractive for investors, therefore we will gradually increase the portion of profit to be paid in dividends.” 

At the moment most of company’s profit is being reinvested into the company, for instance, soon the cogeneration project will
commence.  Possibility of purchasing other producers of pharmaceuticals, herbal medicines or elastic bandages is also not
ruled out.  

Currently AS “Olainfarm” is finishing the registration of capsules of “Noofen” in Russia.  According to company’s forecasts,
in 5-6 years volume of sales of “Noofen” to Russia could reach 6 million euros.

Sales forecasts of AS „Olainfarm” for 2012 provides that unconsolidated sales will reach 40 million lats (56.9 million euros),
but consolidated sales will be as high as 47 million lats (66.9 million euro).

 A/s Olainfarm is one of the biggest pharmaceutical companies in Latvia with nearly 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more
than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia. 

         Information prepared by:
         Salvis Lapins
         Member of the Board
         A/s „Olainfarm”
         Tel: +371 6 7013 717
         Cell: +371 2 6448 873
         E-mail: slapinsh@olainfarm


 

Pielikumi